Walleye Trading
PCVX icon

Walleye Trading’s Vaxcyte PCVX Stock Holding History

Walleye Trading’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,000
Closed -$227K – 4473
2024
Q2 		$227K Sell
3,000
-2,500
-45% -$170K ﹤0.01% 3014
2024
Q1 		$376K Buy
+5,500
New +$381K ﹤0.01% 3002
2023
Q3 		– Sell
-500
Closed -$25K – 5264
2023
Q2 		$25K Buy
+500
New +$23.7K ﹤0.01% 4087
2023
Q1 		– Sell
-12,400
Closed -$595K – 5251
2022
Q4 		$595K Buy
+12,400
New +$487K ﹤0.01% 2668

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Trading's PCVX Position: Q1 2024 in Review

Walleye Trading sold out of Vaxcyte (PCVX) in Q1 2024, closing a stake of 6,741 shares — an estimated $467K sold.

Walleye Trading first reported a position in PCVX in Q3 2022 and held it in 4 quarters. The position peaked at $1.13M in Q4 2022. 251 funds tracked by Wall St. Rank hold PCVX as of Q1 2024.

  • Walleye Trading reported no remaining Vaxcyte position as of Q1 2024 after selling out during the quarter.
  • Walleye Trading sold 6,741 Vaxcyte shares in Q1 2024, an estimated $467K.
  • Walleye Trading first reported a position in Vaxcyte in Q3 2022 and held it in 4 quarters.
  • Walleye Trading's Vaxcyte position peaked at $1.13M in Q4 2022.
  • 251 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.